600513.SH
联环药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 15.64
−6.01%Margins
Gross margin
31.0%
EBITDA margin
3.0%
EBIT margin
-1.4%
Net margin
-4.0%
FCF margin
-10.0%
-9.0%
Return on equity
-2.8%
Return on assets
-1.5%
Return on invested capital
0.70x
Asset turnover
-CNY 40.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026